Other
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
West Pharmaceutical Services Comprehensive Income (Loss), Net of Tax, Attributable to Parent decreased by 5.8% to $119.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.4%, from $142.40M to $119.10M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryOther
SignalHigher is better
VolatilityVolatile
First reportedQ2 2019
Last reportedQ1 2026Apr 23, 2026
How to read this metric
Higher values indicate stronger overall financial performance and equity growth for the parent company.
Detailed definition
This represents the total comprehensive income or loss attributable specifically to the parent company's shareholders af...
Peer comparison
Standard financial reporting metric used by all public companies to show total equity changes.
Metric ID:
other_comprehensive_income_net_of_taxHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $194.30M | $153.10M | $151.00M | $125.00M | $58.00M | $154.60M | $140.00M | $121.80M | $66.80M | $86.70M | $216.60M | $142.40M | $248.60M | $126.40M | $119.10M |
| QoQ Change | — | -21.2% | -1.4% | -17.2% | -53.6% | +166.6% | -9.4% | -13.0% | -45.2% | +29.8% | +149.8% | -34.3% | +74.6% | -49.2% | -5.8% |
| YoY Change | — | — | — | -35.7% | -62.1% | +2.4% | +12.0% | +110.0% | -56.8% | -38.1% | +77.8% | +113.2% | +186.7% | -41.6% | -16.4% |
Range$58.00M – $248.60M
CAGR-13.1%
Avg YoY Growth+21.0%
Median YoY Growth-7.0%
Current Streak2 quarters decline
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's comprehensive income (loss), net of tax, attributable to parent?
- West Pharmaceutical Services (WST) reported comprehensive income (loss), net of tax, attributable to parent of $119.10M in Q1 2026.
- How has West Pharmaceutical Services's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- West Pharmaceutical Services's comprehensive income (loss), net of tax, attributable to parent decreased by 16.4% year-over-year, from $142.40M to $119.10M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- The total comprehensive profit or loss belonging to the parent company's shareholders.